Literature DB >> 1408759

Construction of human XRCC1 minigenes that fully correct the CHO DNA repair mutant EM9.

K W Caldecott1, J D Tucker, L H Thompson.   

Abstract

The human gene that corrects the DNA repair defect of the CHO cell mutant EM9 is designated XRCC1 and is the first human gene to be cloned that has an established role in DNA strand-break repair. In this study, either an XRCC1 cosmid genomic fragment or synthetic oligonucleotides were ligated to an incomplete XRCC1 cDNA to generate two full-length XRCC1 cDNA constructs. The ability of these minigene constructs to restore normal levels of sister chromatid exchange (SCE) to EM9 upon transfection was demonstrated, and the transfectants grew at normal rates in selective medium that is fully toxic to EM9 cells. Constructs in which the XRCC1 open reading frame (ORF) was transcribed from the SV40 early promoter or the genomic XRCC1 native promoter were compared in their efficiency of correction. EM9 transfectants derived from the SV40 promoter displayed fewer SCEs and lower sensitivity to CldUrd than either AA8 wild-type cells or transfectants containing the ORF transcribed from the native promoter.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1408759      PMCID: PMC334187          DOI: 10.1093/nar/20.17.4575

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  10 in total

1.  New Giemsa method for the differential staining of sister chromatids.

Authors:  P Perry; S Wolff
Journal:  Nature       Date:  1974-09-13       Impact factor: 49.962

2.  DNA-strand breaks associated with halogenated pyrimidine incorporation.

Authors:  L E Dillehay; L H Thompson; A V Carrano
Journal:  Mutat Res       Date:  1984 Mar-Apr       Impact factor: 2.433

3.  An ultraviolet light source for consistent differential staining of sister chromatids.

Authors:  J Minkler; D Stetka; A V Carrano
Journal:  Stain Technol       Date:  1978-11

4.  DNA-mediated transfer of a human DNA repair gene that controls sister chromatid exchange.

Authors:  L H Thompson; K W Brookman; J L Minkler; J C Fuscoe; K A Henning; A V Carrano
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

5.  A manyfold increase in sister chromatid exchanges in Bloom's syndrome lymphocytes.

Authors:  R S Chaganti; S Schonberg; J German
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

6.  Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand break repair and sister chromatid exchange.

Authors:  L H Thompson; K W Brookman; N J Jones; S A Allen; A V Carrano
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

7.  A CHO-cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair, and an extraordinary baseline frequency of sister-chromatid exchange.

Authors:  L H Thompson; K W Brookman; L E Dillehay; A V Carrano; J A Mazrimas; C L Mooney; J L Minkler
Journal:  Mutat Res       Date:  1982-08       Impact factor: 2.433

8.  Bloom syndrome: a single complementation group defines patients of diverse ethnic origin.

Authors:  R Weksberg; C Smith; L Anson-Cartwright; K Maloney
Journal:  Am J Hum Genet       Date:  1988-06       Impact factor: 11.025

9.  A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1983-02       Impact factor: 4.272

Review 10.  The scanning model for translation: an update.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

  10 in total
  11 in total

1.  DNA cleavage induced by antitumor antibiotic leinamycin and its biological consequences.

Authors:  Velliyur Viswesh; Allison M Hays; Kent Gates; Daekyu Sun
Journal:  Bioorg Med Chem       Date:  2012-05-23       Impact factor: 3.641

2.  Mutations in hamster single-strand break repair gene XRCC1 causing defective DNA repair.

Authors:  M R Shen; M Z Zdzienicka; H Mohrenweiser; L H Thompson; M P Thelen
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

3.  XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions.

Authors:  A E Vidal; S Boiteux; I D Hickson; J P Radicella
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

4.  Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination.

Authors:  Niklas Schultz; Elena Lopez; Nasrollah Saleh-Gohari; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

5.  An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III.

Authors:  K W Caldecott; C K McKeown; J D Tucker; S Ljungquist; L H Thompson
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

6.  Characterization of the XRCC1-DNA ligase III complex in vitro and its absence from mutant hamster cells.

Authors:  K W Caldecott; J D Tucker; L H Stanker; L H Thompson
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

7.  Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1.

Authors:  Thomas Iftner; Michaela Elbel; Betti Schopp; Thomas Hiller; Joanna I Loizou; Keith W Caldecott; Frank Stubenrauch
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

8.  Partial complementation of a DNA ligase I deficiency by DNA ligase III and its impact on cell survival and telomere stability in mammalian cells.

Authors:  Catherine Le Chalony; Françoise Hoffschir; Laurent R Gauthier; Julia Gross; Denis S Biard; François D Boussin; Vincent Pennaneach
Journal:  Cell Mol Life Sci       Date:  2012-03-30       Impact factor: 9.261

9.  Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no detectable in vivo DNA double-strand breaks.

Authors:  Cecilia Lundin; Matthew North; Klaus Erixon; Kevin Walters; Dag Jenssen; Alastair S H Goldman; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2005-07-11       Impact factor: 16.971

10.  Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells.

Authors:  Rebeka Sultana; Tarek Abdel-Fatah; Christina Perry; Paul Moseley; Nada Albarakti; Vivek Mohan; Claire Seedhouse; Stephen Chan; Srinivasan Madhusudan
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.